Achieve Life Sciences ACHV Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Achieve Life Sciences's debt issuance cost amortization?
- Achieve Life Sciences (ACHV) reported debt issuance cost amortization of $12K in Q1 2026.
- How has Achieve Life Sciences's debt issuance cost amortization changed year-over-year?
- Achieve Life Sciences's debt issuance cost amortization decreased by 14.3% year-over-year, from $14K to $12K.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).